Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.0640
-0.0200 (-23.81%)
Oct 27, 2026, 4:19 PM AEDT
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 62.19 million as of October 27, 2026. It is the 30,624th most valuable company in the world and the 701st biggest in Australia. Its market cap has decreased by 69.56% in one year.
Market Cap
62.19M
Enterprise Value
48.47M
Revenue
19.07M
Global Rank
Country Rank
#701 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 62.19M, a decrease of -68.38%. That is a compound annual growth rate of -19.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 62.19M | -72.28% |
| Dec 31, 2025 | 224.36M | 756.38% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EMVision Medical Devices | 141.76M |
| EBR Systems | 114.14M |
| SomnoMed | 63.73M |
| Saluda Medical | 63.01M |
| Epiminder | 55.25M |
| Cyclopharm | 47.15M |
| HeraMED | 46.35M |
| Compumedics | 45.95M |